Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardiff Oncology (CRDF) Non-Current Debt (2016 - 2020)

Cardiff Oncology (CRDF) has disclosed Non-Current Debt for 6 consecutive years, with $234270.0 as the latest value for Q2 2020.

  • Quarterly Non-Current Debt changed N/A to $234270.0 in Q2 2020 from the year-ago period, while the trailing twelve-month figure was $234270.0 through Jun 2020, changed N/A year-over-year, with the annual reading at $14.2 million for FY2016, 26.05% up from the prior year.
  • Non-Current Debt hit $234270.0 in Q2 2020 for Cardiff Oncology, down from $12.7 million in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $15.6 million in Q3 2016 to a low of $234270.0 in Q2 2020.
  • Historically, Non-Current Debt has averaged $10.4 million across 3 years, with a median of $11.5 million in 2016.
  • Biggest YoY gain for Non-Current Debt was 35.39% in 2016; the steepest drop was 29.89% in 2016.
  • Year by year, Non-Current Debt stood at $14.2 million in 2016, then fell by 10.42% to $12.7 million in 2017, then crashed by 98.16% to $234270.0 in 2020.
  • Business Quant data shows Non-Current Debt for CRDF at $234270.0 in Q2 2020, $12.7 million in Q1 2017, and $14.2 million in Q4 2016.